Loveless Wealth Management’s GSK GSK Stock Holding History

Loveless Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$653K	Buy	12,008 +336	+3%	+$18.5K	0.43%	76
2022 Q1	$636K	Buy	11,672 +252	+2%	+$13.7K	0.36%	82
2021 Q4	$630K	Sell	11,420 -64	-0.6%	-$3.33K	0.35%	86
2021 Q3	$549K	Buy	11,484 +300	+3%	+$15.1K	0.33%	89
2021 Q2	$557K	Hold	11,184	–	–	0.34%	88
2021 Q1	$499K	Hold	11,184	–	–	0.33%	89
2020 Q4	$514K	Sell	11,184 -100	-0.9%	-$4.59K	0.38%	78
2020 Q3	$531K	Buy	11,284 +360	+3%	+$18K	0.45%	68
2020 Q2	$557K	Sell	10,924 -80	-0.7%	-$4.1K	0.52%	65
2020 Q1	$521K	Buy	11,004 +184	+2%	+$9.81K	0.61%	55
2019 Q4	$629K	Buy	+10,820	New	+$602K	0.54%	62

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Loveless Wealth Management's GSK Position: Q2 2022 in Review

Loveless Wealth Management increased its GSK (GSK) stake by 2.9% in Q2 2022, buying an estimated $18.5K and bringing the position to 12,008 shares worth $653K. The position accounts for 0.43% of the portfolio, ranked #76.

Loveless Wealth Management first reported a position in GSK in Q4 2019 and has held it in 11 quarters since. 900 funds tracked by Wall St. Rank hold GSK as of Q2 2022.

Loveless Wealth Management held 12,008 shares of GSK worth $653K as of Q2 2022.
Loveless Wealth Management bought 336 GSK shares in Q2 2022, an estimated $18.5K.
GSK made up 0.43% of Loveless Wealth Management's portfolio in Q2 2022, its #76 holding.
Loveless Wealth Management first reported a position in GSK in Q4 2019 and has held it in 11 quarters since.
900 funds tracked by Wall St. Rank held GSK as of Q2 2022.

Based on Loveless Wealth Management's 13F filing for Q2 2022, filed 22 Jul 2022.